| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |